FDA Inspection 636070 — Chemolee Lab Corporation

Chemolee Lab Corporation — FEI 1642813

The FDA completed an inspection of Chemolee Lab Corporation on December 21, 2009 in Irving, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 17 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 21, 2009
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Irving, TX (United States)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
141821 CFR 211.42(c)(7)Quarantined Drug Products Area
149521 CFR 211.122(a)Written procedures describing in detail
150521 CFR 211.122(d)Label storage access limited to authorized personnel
155021 CFR 211.125(f)Procedures Written and Followed
188621 CFR 211.165(c)Sampling and testing plans not described
191221 CFR 211.166(a)Written program not followed
191421 CFR 211.166(a)Lack of written stability program
200821 CFR 211.186(a)Written procedures followed
200921 CFR 211.188Prepared for each batch, include complete information
202721 CFR 211.192Investigations of discrepancies, failures
357021 CFR 211.100(a)Approval and review of procedures
358521 CFR 211.110(a)Control procedures to monitor and validate performance
360321 CFR 211.160(b)Scientifically sound laboratory controls
363221 CFR 211.170(b)Annual visual exams of drug products
430721 CFR 211.80(d)Status of Each Lot Identified
431421 CFR 211.84(d)(2)Reports of Analysis (Components)